BFEC
PACB icon

Benjamin F. Edwards & Company’s Pacific Biosciences PACB Stock Holding History

Benjamin F. Edwards & Company’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$194K Buy
141,830
+139,408
+5,756% +$282K ﹤0.01% 916
2024
Q1 		$9K Buy
+2,422
New +$14.2K ﹤0.01% 1733

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Benjamin F. Edwards & Company's PACB Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Pacific Biosciences (PACB) stake by 5,756% in Q2 2024, buying an estimated $282K and bringing the position to 141,830 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #916.

Benjamin F. Edwards & Company first reported a position in PACB in Q1 2024 and has held it in 2 quarters since. 229 funds tracked by Wall St. Rank hold PACB as of Q2 2024.

  • Benjamin F. Edwards & Company held 141,830 shares of Pacific Biosciences worth $194K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 139,408 Pacific Biosciences shares in Q2 2024, an estimated $282K.
  • Pacific Biosciences made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #916 holding.
  • Benjamin F. Edwards & Company first reported a position in Pacific Biosciences in Q1 2024 and has held it in 2 quarters since.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.